2 news items
Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote "FOR" Re-Election of Its Highly Qualified Directors
CWCO
SKYX
VVOS
20 May 24
to the Board's effectiveness in managing risk and providing guidance that positions the Company for long-term success. Further, of the eight directors, seven
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
VVOS
14 May 24
opportunities. By doing this, we expect to position Vivos for long-term, sustainable revenue growth and ultimate profitability
- Prev
- 1
- Next